Company intelligence / Profile preview

Guangdong Hongzhi Biotechnology

Shantou, Guangdong, China

Ownership: Private
Development stage: Commercial

Overview

Guangdong Hongzhi Biotechnology develops, manufactures, and markets advanced wound care products, including negative pressure wound therapy systems and biological dressings. The company holds multiple national invention certificates for its technologies and is recognized as a high-tech leader in the Chinese wound care sector[3][4][5]. Its products are ISO 13485 certified for quality management in medical devices[5].

Therapeutic areas: Dermatology
Modalities: DeviceWound covering / skin substitutesNegative pressure wound therapy system (vacuum-assisted closure)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Guangdong Hongzhi Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangdong Hongzhi Biotechnology.

Explore the full profile